Skip to main content
ACON
NASDAQ Industrial Applications And Services

Aclarion Q3 Loss Widens to $2.62M as Cash Builds to $14.2M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.56
Mkt Cap
$4.496M
52W Low
$1.544
52W High
$9.36
52W Position info
1.0% above low
Off High info
83% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ACON is trading near its 52-week low of $1.544 (1.0% above the low) on light trading volume (0.3× avg).

Summary

Aclarion's Q3 2026 loss widened to $2.62 million on an 82% jump in G&A, while revenue rose 78.1% to $33,733 and cash stood at $14.2 million — enough, management says, for at least twelve months.


Key Events · Earnings and Guidance · ACON

  • Q3 Loss Widens on Cost Surge

    Net loss was $2,622,035 for the three months ended September 30, 2026 versus $1,706,294 a year earlier; nine-month loss reached $8,223,161 from $5,344,487.

  • Revenue Up but Still Tiny

    Net revenue rose 78.1% to $33,733 in Q3 and 39.9% to $80,081 for nine months, driven by NOCISCAN reports sold into the UK market after local coverage decisions.

  • G&A Jumped 82%

    General and administrative expense was $1,639,456 in Q3 versus $900,904, with salaries and benefits up 146.6% to $1,039,447 and stock-based compensation of $299,544 versus $16,746.

  • Cash Covers Twelve Months

    Cash, cash equivalents and restricted cash totaled $14,212,566 at September 30, 2026; management states this funds operating expenses and capital expenditures for at least twelve months from issuance.


Analysis · ACON · Industrial Applications And Services

The headline for Aclarion is the widening loss: $2.62 million in the third quarter versus $1.71 million a year earlier, and $8.22 million for nine months against $5.34 million. An 82% jump in general and administrative costs — tied to salaries, stock compensation and bonus accruals — drove the deterioration. Revenue, however, is finally moving: $33,733 in the quarter, up 78.1%, and $80,081 for nine months, up 39.9%, as NOCISCAN reports sold into the UK market following local coverage decisions. For a company this size, the balance sheet is the real story — $14.2 million of cash and restricted cash at September 30, 2026, after a $10.4 million January registered direct offering, which management says funds at least twelve months of operations. That runway claim is what keeps the equity story alive. The offset: the January raise was priced at $5.18 per share versus a stock now trading near $1.56, so the dilution was taken at a much higher valuation than the market currently assigns.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ACON was trading at $1.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.5M. The 52-week trading range was $1.54 to $9.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACON - Latest Insights

ACON
Oct 08, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.35
Real-time Price: $1.34 info
Change: -$1.01 (-43%) info
Market Cap: $4.093M info
ACON
Aug 18, 2026, 8:30 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $2.71
Real-time Price: $1.34 info
Change: -$1.37 (-51%) info
Market Cap: $4.093M info
ACON
Aug 17, 2026, 8:30 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $2.46
Real-time Price: $1.34 info
Change: -$1.12 (-46%) info
Market Cap: $4.093M info
ACON
Aug 06, 2026, 9:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.36
Real-time Price: $1.34 info
Change: -$1.02 (-43%) info
Market Cap: $4.093M info
ACON
Jun 09, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.35
Real-time Price: $1.34 info
Change: -$2.01 (-60%) info
Market Cap: $4.093M info